Cargando…
Leveraging Molecular Diagnostic Technologies to Close the Global Cancer Pathology Gap
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812500/ https://www.ncbi.nlm.nih.gov/pubmed/36252158 http://dx.doi.org/10.1200/GO.22.00182 |
_version_ | 1784863740925050880 |
---|---|
author | Erfani, Parsa Bates, Michael Garcia-Gonzalez, Pat Milner, Dan A. Rebbeck, Timothy R. Ruhangaza, Deogratias Shulman, Lawrence N. Fadelu, Temidayo |
author_facet | Erfani, Parsa Bates, Michael Garcia-Gonzalez, Pat Milner, Dan A. Rebbeck, Timothy R. Ruhangaza, Deogratias Shulman, Lawrence N. Fadelu, Temidayo |
author_sort | Erfani, Parsa |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9812500 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-98125002023-01-05 Leveraging Molecular Diagnostic Technologies to Close the Global Cancer Pathology Gap Erfani, Parsa Bates, Michael Garcia-Gonzalez, Pat Milner, Dan A. Rebbeck, Timothy R. Ruhangaza, Deogratias Shulman, Lawrence N. Fadelu, Temidayo JCO Glob Oncol COMMENTARIES Wolters Kluwer Health 2022-10-17 /pmc/articles/PMC9812500/ /pubmed/36252158 http://dx.doi.org/10.1200/GO.22.00182 Text en © 2022 by American Society of Clinical Oncology https://creativecommons.org/licenses/by-nc-nd/4.0/Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | COMMENTARIES Erfani, Parsa Bates, Michael Garcia-Gonzalez, Pat Milner, Dan A. Rebbeck, Timothy R. Ruhangaza, Deogratias Shulman, Lawrence N. Fadelu, Temidayo Leveraging Molecular Diagnostic Technologies to Close the Global Cancer Pathology Gap |
title | Leveraging Molecular Diagnostic Technologies to Close the Global Cancer Pathology Gap |
title_full | Leveraging Molecular Diagnostic Technologies to Close the Global Cancer Pathology Gap |
title_fullStr | Leveraging Molecular Diagnostic Technologies to Close the Global Cancer Pathology Gap |
title_full_unstemmed | Leveraging Molecular Diagnostic Technologies to Close the Global Cancer Pathology Gap |
title_short | Leveraging Molecular Diagnostic Technologies to Close the Global Cancer Pathology Gap |
title_sort | leveraging molecular diagnostic technologies to close the global cancer pathology gap |
topic | COMMENTARIES |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812500/ https://www.ncbi.nlm.nih.gov/pubmed/36252158 http://dx.doi.org/10.1200/GO.22.00182 |
work_keys_str_mv | AT erfaniparsa leveragingmoleculardiagnostictechnologiestoclosetheglobalcancerpathologygap AT batesmichael leveragingmoleculardiagnostictechnologiestoclosetheglobalcancerpathologygap AT garciagonzalezpat leveragingmoleculardiagnostictechnologiestoclosetheglobalcancerpathologygap AT milnerdana leveragingmoleculardiagnostictechnologiestoclosetheglobalcancerpathologygap AT rebbecktimothyr leveragingmoleculardiagnostictechnologiestoclosetheglobalcancerpathologygap AT ruhangazadeogratias leveragingmoleculardiagnostictechnologiestoclosetheglobalcancerpathologygap AT shulmanlawrencen leveragingmoleculardiagnostictechnologiestoclosetheglobalcancerpathologygap AT fadelutemidayo leveragingmoleculardiagnostictechnologiestoclosetheglobalcancerpathologygap |